TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir.

Genovefa A Papanicolaou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.